Crystal structure of the complex between thrombin and the central "E" region of fibrin.

Nonsubstrate interactions of thrombin with fibrin play an important role in modulating its procoagulant activity. To establish the structural basis for these interactions, we crystallized d-Phe-Pro-Arg-chloromethyl ketone-inhibited human thrombin in complex with a fragment, E(ht), corresponding to the central region of human fibrin, and solved its structure at 3.65-A resolution. The structure revealed that the complex consists of two thrombin molecules bound to opposite sides of the central part of E(ht) in a way that seems to provide proper orientation of their catalytic triads for cleavage of fibrinogen fibrinopeptides. As expected, binding occurs through thrombin's anion-binding exosite I. However, only part of it is involved in forming an interface with the complementary negatively charged surface of E(ht). Among residues constituting the interface, Phe-34, Ser-36A, Leu-65, Tyr-76, Arg-77A, Ile-82, and Lys-110 of thrombin and the A alpha chain Trp-33, Phe-35, Asp-38, Glu-39, the B beta chain Ala-68 and Asp-69, and the gamma chain Asp-27 and Ser-30 of E(ht) form a net of polar contacts surrounding a well defined hydrophobic interior. Thus, despite the highly charged nature of the interacting surfaces, hydrophobic contacts make a substantial contribution to the interaction.

[1]  E. Di Cera,et al.  Three-dimensional Modeling of Thrombin-Fibrinogen Interaction* , 2002, The Journal of Biological Chemistry.

[2]  J. Hainfeld,et al.  Fibrinogen Assembly and Crosslinking on a Fibrin Fragment E Template , 2002, Thrombosis and Haemostasis.

[3]  C. Gibbs,et al.  Identification of Critical Residues on Thrombin Mediating Its Interaction with Fibrin , 2001, Thrombosis and Haemostasis.

[4]  R. Doolittle,et al.  Crystal structure of native chicken fibrinogen at 2.7 A resolution. , 2001, Biochemistry.

[5]  R. Dominguez,et al.  Crystal structure of the central region of bovine fibrinogen (E5 fragment) at 1.4-Å resolution , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Weisel,et al.  The Structure and Function of the αC Domains of Fibrinogen , 2001 .

[7]  J. Pflugrath,et al.  The finer things in X-ray diffraction data collection. , 1999, Acta crystallographica. Section D, Biological crystallography.

[8]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[9]  R. Doolittle,et al.  Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin , 1997, Nature.

[10]  S. Olson,et al.  Inactivation of Thrombin by Antithrombin Is Accompanied by Inactivation of Regulatory Exosite I* , 1997, The Journal of Biological Chemistry.

[11]  S. Béguin,et al.  Thrombin, Fibrin and Platelets: a Resonance Loop in which von Willebrand Factor is a Necessary Link , 1997, Thrombosis and Haemostasis.

[12]  E. Davie,et al.  Crystal structure of a 30 kDa C-terminal fragment from the γ chain of human fibrinogen , 1997 .

[13]  P. Hogg,et al.  Binding of Fibrin Monomer and Heparin to Thrombin in a Ternary Complex Alters the Environment of the Thrombin Catalytic Site, Reduces Affinity for Hirudin, and Inhibits Cleavage of Fibrinogen* , 1996, The Journal of Biological Chemistry.

[14]  K. Siebenlist,et al.  Identification and Characterization of the Thrombin Binding Sites on Fibrin* , 1996, The Journal of Biological Chemistry.

[15]  B. Blombäck Fibrinogen and fibrin--proteins with complex roles in hemostasis and thrombosis. , 1996, Thrombosis research.

[16]  S. Lord,et al.  Strategy for recombinant multichain protein synthesis: fibrinogen B beta-chain variants as thrombin substrates. , 1996, Biochemistry.

[17]  C. Gibbs,et al.  Functional Mapping of the Surface Residues of Human Thrombin (*) , 1995, The Journal of Biological Chemistry.

[18]  R. Huber,et al.  The structure of residues 7-16 of the A alpha-chain of human fibrinogen bound to bovine thrombin at 2.3-A resolution. , 1994, The Journal of biological chemistry.

[19]  D. McRee Practical Protein Crystallography , 1993 .

[20]  S. Lord,et al.  The fibrinogen sequences that interact with thrombin , 1993 .

[21]  S. Lord,et al.  Molecular basis of fibrinogen Naples associated with defective thrombin binding and thrombophilia. Homozygous substitution of B beta 68 Ala----Thr. , 1992, The Journal of clinical investigation.

[22]  H Oschkinat,et al.  The interaction of thrombin with fibrinogen. A structural basis for its specificity. , 1992, European journal of biochemistry.

[23]  D. Turk,et al.  The refined 1.9‐Å X‐ray crystal structure of d‐Phe‐Pro‐Arg chloromethylketone‐inhibited human α‐thrombin: Structure analysis, overall structure, electrostatic properties, detailed active‐site geometry, and structure‐function relationships , 1992, Protein science : a publication of the Protein Society.

[24]  M. Margaglione,et al.  A role for platelets and thrombin in the juvenile stroke of two siblings with defective thrombin-adsorbing capacity of fibrin(ogen). , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[25]  K. Siebenlist,et al.  The polymerization and thrombin-binding properties of des-(B beta 1-42)-fibrin. , 1990, The Journal of biological chemistry.

[26]  S. Lord,et al.  Analysis of fibrinogen alpha residues 27-50: interactions with thrombin. , 1990, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[27]  W. Bode,et al.  Crystal structure of the thrombin‐hirudin complex: a novel mode of serine protease inhibition. , 1990, The EMBO journal.

[28]  R. Huber,et al.  The structure of a complex of recombinant hirudin and human alpha-thrombin. , 1990, Science.

[29]  P. Hogg,et al.  Formation of a ternary complex between thrombin, fibrin monomer, and heparin influences the action of thrombin on its substrates. , 1990, The Journal of biological chemistry.

[30]  R. Huber,et al.  The refined 1.9 A crystal structure of human alpha‐thrombin: interaction with D‐Phe‐Pro‐Arg chloromethylketone and significance of the Tyr‐Pro‐Pro‐Trp insertion segment. , 1989, The EMBO journal.

[31]  P. Hogg,et al.  Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III: implications for heparin efficacy. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[32]  H. Scheraga,et al.  High-resolution NMR studies of fibrinogen-like peptides in solution: interaction of thrombin with residues 1-23 of the A alpha chain of human fibrinogen. , 1989, Biochemistry.

[33]  M. Zabinski,et al.  Anion-binding exosite of human alpha-thrombin and fibrin(ogen) recognition. , 1988, Biochemistry.

[34]  J. McDonagh,et al.  Inhibited thrombins. Interactions with fibrinogen and fibrin. , 1987, The Biochemical journal.

[35]  P. Mannucci,et al.  Fibrinogen Milano II: A Congenital Dysfibrinogenaemia Associated with Juvenile Arterial and Venous Thrombosis , 1986, Thrombosis and Haemostasis.

[36]  J. Koehn,et al.  Characterization of fibrinogen New York 1. A dysfunctional fibrinogen with a deletion of B beta(9-72) corresponding exactly to exon 2 of the gene. , 1985, The Journal of biological chemistry.

[37]  A. Budzynski,et al.  Fibrinogen degradation by hementin, a fibrinogenolytic anticoagulant from the salivary glands of the leech Haementeria ghilianii. , 1984, The Journal of laboratory and clinical medicine.

[38]  J. McDonagh,et al.  Studies on the mechanism of thrombin. Interaction with fibrin. , 1983, The Journal of biological chemistry.

[39]  C. Francis,et al.  Thrombin activity of fibrin thrombi and soluble plasmic derivatives. , 1983, The Journal of laboratory and clinical medicine.

[40]  C. Esmon,et al.  Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation. , 1982, The Journal of biological chemistry.

[41]  K. Kaplan,et al.  The binding of thrombin by fibrin. , 1979, The Journal of biological chemistry.

[42]  H. Al-Mondhiry,et al.  Fibrinogen ""New York"--an abnormal fibrinogen associated with thromboembolism: functional evaluation. , 1975, Blood.

[43]  M. Mosesson Antithrombin I. Inhibition of thrombin generation in plasma by fibrin formation , 2003, Thrombosis and Haemostasis.

[44]  T. Yeates,et al.  [22] Detecting and overcoming crystal twinning. , 1997, Methods in enzymology.

[45]  G. Sheldrick,et al.  SHELXL: high-resolution refinement. , 1997, Methods in enzymology.

[46]  M. Mosesson Thrombin interactions with fibrinogen and fibrin. , 1993, Seminars in thrombosis and hemostasis.

[47]  W. Bode,et al.  A Model for the Specificity of Fibrinogen Cleavage by Thrombin , 1993, Seminars in thrombosis and hemostasis.

[48]  W. Bode,et al.  Spatial Structure of Thrombin as a Guide to Its Multiple Sites of Interaction , 1993, Seminars in thrombosis and hemostasis.

[49]  R. Doolittle Fibrinogen and fibrin. , 1984, Annual review of biochemistry.